Björn E Clausen

23PUBLICATIONS
86CO-AUTHORS
Applied immunology (incl. antibody engineering, xenotransplantation and t-cell therapies)Innate immunityEndodonticsMolecular targetsCancer therapy (excl. chemotherapy and radiation therapy)
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (23)

|Mar 19, 2026
Tim-3-targeted vaccines overcome tumor immunosuppression and reduce cDC1 dependence to elicit potent anti-tumor immunity.

Chunmei Fu, Tianle Ma, Björn E Clausen

|Feb 23, 2026
B cells maintain the homeostasis of splenic marginal zone antigen-presenting cells to promote the antiviral CD8+ T-cell response.

Xinyuan Liu, Filiz Demircik, Mariia Antipova

|Sep 02, 2025
AhR signaling in skin-resident CD207+ cells is involved in UV-B-induced amelioration of neuroinflammation.

Nadine Mykicki, Johannes A Eble, Heike Weighardt

|Apr 02, 2025
Guidelines and Advances in Basic and Applied Dendritic Cell Biology.

Björn E Clausen, Diana Dudziak

|Feb 24, 2025
RORγt-expressing dendritic cells are functionally versatile and evolutionarily conserved antigen-presenting cells.

Hamsa Narasimhan, Maria L Richter, Ramin Shakiba

Pageof 4